Literature DB >> 8994247

Refinements in managing maternal weight adjustment for interpreting prenatal screening results.

L M Neveux1, G E Palomaki, D A Larrivee, G J Knight, J E Haddow.   

Abstract

This study examines the relationship between maternal weight and serum levels of alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin in a population of 47,585 women being provided with prenatal screening for Down's syndrome and open neural tube defects. The study population contains sufficient numbers of women at the extremes of weight to allow the determination that a reciprocal-linear equation more accurately describes the weight relationship for two of the three analytes than the currently used log-linear equations. The reciprocal-linear equations, while more appropriate, provide only a minimal advantage over the log-linear equations. A more important finding is that published weight equations may not be optimal for some screening programmes, due to differences in the mean weight of the populations being tested. Screening programmes are encouraged to calculate their own weight correction formulae, based on data from their own population, and to monitor the mean maternal weight to detect when modifications in the weight correction formulae might be indicated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8994247     DOI: 10.1002/(SICI)1097-0223(199612)16:12<1115::AID-PD3>3.0.CO;2-6

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  19 in total

Review 1.  Super obesity in pregnancy: difficulties in clinical management.

Authors:  A Martin; I Krishna; J Ellis; R Paccione; M Badell
Journal:  J Perinatol       Date:  2014-02-06       Impact factor: 2.521

2.  Serum Progesterone Levels in Pregnant Women with Obstructive Sleep Apnea: A Case Control Study.

Authors:  Jennifer Lee; Elizabeth E Eklund; Geralyn Lambert-Messerlian; Glenn E Palomaki; Kristen Butterfield; Patrizia Curran; Ghada Bourjeily
Journal:  J Womens Health (Larchmt)       Date:  2017-01-19       Impact factor: 2.681

3.  Cell-Free DNA (cfDNA) Fetal Fraction in Early- and Late-Onset Fetal Growth Restriction.

Authors:  Danila Morano; Stefania Rossi; Cristina Lapucci; Maria Carla Pittalis; Antonio Farina
Journal:  Mol Diagn Ther       Date:  2018-10       Impact factor: 4.074

Review 4.  First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 5.  First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 6.  Obesity and the risk and detection of fetal malformations.

Authors:  Diana Racusin; Blair Stevens; Genevieve Campbell; Kjersti M Aagaard
Journal:  Semin Perinatol       Date:  2012-06       Impact factor: 3.300

7.  A multifactorial relationship exists between total circulating cell-free DNA levels and maternal BMI.

Authors:  Neeta L Vora; Kirby L Johnson; Subhabrata Basu; Patrick M Catalano; Sylvie Hauguel-De Mouzon; Diana W Bianchi
Journal:  Prenat Diagn       Date:  2012-06-21       Impact factor: 3.050

8.  Midpregnancy levels of angiogenic markers in relation to maternal characteristics.

Authors:  Renée S Mijal; Claudia B Holzman; Sarosh Rana; S Ananth Karumanchi; Jianling Wang; Alla Sikorskii
Journal:  Am J Obstet Gynecol       Date:  2010-12-10       Impact factor: 8.661

9.  Weight correction of MoM values: which method?

Authors:  T M Reynolds; G Vranken; J Van Nueten
Journal:  J Clin Pathol       Date:  2006-04-07       Impact factor: 3.411

10.  Variability in thyroid-stimulating hormone suppression by human chorionic [corrected] gonadotropin during early pregnancy.

Authors:  James E Haddow; Monica R McClain; Geralyn Lambert-Messerlian; Glenn E Palomaki; Jacob A Canick; Jane Cleary-Goldman; Fergal D Malone; T Flint Porter; David A Nyberg; Peter Bernstein; Mary E D'Alton
Journal:  J Clin Endocrinol Metab       Date:  2008-06-10       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.